A joint Singaporean-Chinese research team has developed an Evans Blue-modified lipid nanoparticle platform that directs mRNA ...

The same mRNA technology used in COVID-19 vaccines may offer a powerful new way to prevent long-term muscle damage caused by ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...

According to researchers, the adapted treatment could help to prevent muscle damage and permanent physical impacts.

The study was published in Nature Biotechnology last month and marks a shift in scientists’ understanding of how to efficiently cure specific diseases.

HOUSTON – The federal government is ending funding for some vaccine development projects using messenger RNA (mRNA) technology, a move that could affect local researchers and ongoing projects.

National Institutes of Health (NIH) Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research contracts because the general public does not ...

Researchers advance mRNA cancer therapies as France tests new methods, while the FDA approves Bayer’s Hyrnuo for HER2-mutated ...

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel ...